For help on how to get the results you want, see our search tips.
1743 results
Keyword Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Adenuric
febuxostat, Gout
Date of authorisation: 21/04/2008, Revision: 23, Authorised, Last updated: 20/04/2023 -
List item
Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 10/10/2009,
, Revision: 11, Authorised, Last updated: 08/06/2022
-
List item
Human medicine European public assessment report (EPAR): Adlumiz
anamorelin hydrochloride, Cachexia; Anorexia; Carcinoma, Non-Small-Cell Lung
Date of refusal: 16/11/2017, Refused, Last updated: 30/11/2017 -
List item
Human medicine European public assessment report (EPAR): Adrovance
colecalciferol, alendronic acid (as sodium trihydrate), Osteoporosis, Postmenopausal
Date of authorisation: 04/01/2007, Revision: 24, Authorised, Last updated: 05/11/2021 -
List item
Human medicine European public assessment report (EPAR): Adtralza
Tralokinumab, Dermatitis, Atopic
Date of authorisation: 17/06/2021,
, Revision: 2, Authorised, Last updated: 14/12/2022
-
List item
Human medicine European public assessment report (EPAR): Advagraf
tacrolimus, Graft Rejection
Date of authorisation: 23/04/2007, Revision: 25, Authorised, Last updated: 15/11/2022 -
List item
Human medicine European public assessment report (EPAR): Advate (updated)
octocog alfa, Hemophilia A
Date of authorisation: 02/03/2004, Revision: 31, Authorised, Last updated: 24/08/2023 -
List item
Human medicine European public assessment report (EPAR): Adynovi
rurioctocog alfa pegol, Hemophilia A
Date of authorisation: 08/01/2018,, Revision: 9, Authorised, Last updated: 02/06/2023
-
List item
Human medicine European public assessment report (EPAR): Aerinaze
desloratadine, pseudophedrine sulfate, Rhinitis, Allergic, Seasonal
Date of authorisation: 30/07/2007, Revision: 22, Authorised, Last updated: 07/12/2022 -
List item
Human medicine European public assessment report (EPAR): Aerius
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 50, Authorised, Last updated: 02/08/2023 -
List item
Human medicine European public assessment report (EPAR): Aerivio Spiromax
salmeterol xinafoate, fluticasone propionate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 15/01/2020 -
List item
Human medicine European public assessment report (EPAR): Afinitor
everolimus, Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms
Date of authorisation: 02/08/2009, Revision: 30, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Aflunov
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 28/11/2010, Revision: 15, Authorised, Last updated: 03/10/2022 -
List item
Human medicine European public assessment report (EPAR): Afstyla
lonoctocog alfa, Hemophilia A
Date of authorisation: 04/01/2017, Revision: 10, Authorised, Last updated: 25/07/2022 -
List item
Human medicine European public assessment report (EPAR): Agenerase
amprenavir, HIV Infections
Date of authorisation: 20/10/2000, Revision: 18, Withdrawn, Last updated: 21/06/2011 -
List item
Human medicine European public assessment report (EPAR): Aimovig
erenumab, Migraine Disorders
Date of authorisation: 26/07/2018,, Revision: 11, Authorised, Last updated: 14/08/2023
-
List item
Human medicine European public assessment report (EPAR): Airexar Spiromax
salmeterol, fluticasone propionate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 02/07/2019 -
List item
Human medicine European public assessment report (EPAR): Ajovy
fremanezumab, Migraine Disorders
Date of authorisation: 28/03/2019,, Revision: 9, Authorised, Last updated: 23/05/2023
-
List item
Human medicine European public assessment report (EPAR): Akeega
abiraterone acetate, Niraparib tosilate monohydrate, Prostatic Neoplasms, Castration-Resistant
Date of authorisation: 19/04/2023, Authorised, Last updated: 02/06/2023 -
List item
Human medicine European public assessment report (EPAR): Akynzeo (updated)
netupitant, palonosetron hydrochloride, Vomiting; Neoplasms; Nausea; Cancer
Date of authorisation: 27/05/2015, Revision: 16, Authorised, Last updated: 08/09/2023 -
List item
Human medicine European public assessment report (EPAR): Aldara
imiquimod, Condylomata Acuminata; Keratosis; Keratosis, Actinic; Carcinoma, Basal Cell
Date of authorisation: 18/09/1998, Revision: 31, Authorised, Last updated: 06/07/2023 -
List item
Human medicine European public assessment report (EPAR): Aldurazyme
laronidase, Mucopolysaccharidosis I
Date of authorisation: 09/06/2003, Revision: 24, Authorised, Last updated: 14/04/2023 -
List item
Human medicine European public assessment report (EPAR): Alecensa
alectinib hydrochloride, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 16/02/2017,, Revision: 14, Authorised, Last updated: 29/03/2023
-
List item
Human medicine European public assessment report (EPAR): Alimta
pemetrexed, Mesothelioma; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2004, Revision: 27, Authorised, Last updated: 03/05/2022 -
List item
Human medicine European public assessment report (EPAR): Alisade
fluticasone furoate, Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
Date of authorisation: 06/10/2008, Revision: 4, Withdrawn, Last updated: 18/10/2011